Hailey Hailey disease-a rare case report
Abstract
Keywords
Full Text:
PDFReferences
Persić-Vojinović S, Milavec-Puretić V, Dobrić I, Rados J, Spoljar S. Disseminated Hailey-Hailey disease treated with topical tacrolimus and oral erythromycin: Case report and review of the literature. Acta Dermatovenerol Croat. 2006;14:253–7.
Schirren H, Schirren CG, Schluppen EM, Volkenandt M, Kind P. Exacerbation of the Hailey-Hailey disease with herpes simplex virus. Detection with polymerase chain reaction. Hautarzt. 1995;46:494-7.
Valia AR, Ramesh V, Jerajani HR, Fernandez RJ. In: R G Valia, Ameet R Valia, eds. IADVL Textbook of Dermatology Blistering Disorder. 3rd Ed, Vol 1, Bhalani Publishers; 2008: 1127-1128.
Sangoram SS, Indurkar VA, Amin-Hon VS, Nishigandh. Hailey-Hailey Disease- A Case Report. Pravara Med Rev. 2010;2:31-2.
Cheng TS, Jong KK. A man with familial flexural rash: a case of Hailey-Hailey; Disease. Hong Kong J Dermatol Venereol. 2005;13:98-100.
Michel B. "Familial benign chronic pemphigus" by Hailey and Hailey, April 1939. Commentary: Hailey-Hailey disease, familial benign chronic pemphigus. Arch Dermatol. 1982;118:774-83.
Warycha M, Patel R, Meehan S, Merola JF. Familial benign chronic pemphigus (Hailey- Hailey disease). Dermatol Online J. 2009;15:15.
Mashiko M, Akiyama M, Tsuji-Abe Y, Shimizu H. Bacterial infection-induced generalized HaileyHailey disease successfully treated by etretinate. Clin Exp Dermatol. 2006;31:57-9.
Chlebicka I, Jankowska-Konsur A, Maj J, Plomer-Niezgoda E, Cezary Szepietowski J. Generalized Hailey-Hailey disease triggered by nonsteroidal antiinflammatory drug-induced rash: case report. Acta Dermatovenerol Croat. 2012;20(3):201-3.
Thapa DP, Jha AK, Pudasaini S, Kharel C, Shrestha S. Genital Hailey-Hailey disease: A case report. Our Dermatol Online. 2013;4:87-8.
Botvinick I. Familial benign pemphigus with oral mucous membrane lesions. Cutis. 1973;12:371-3.
Holst VA, Fair KP, Wilson BB, Patterson JW. Squamous cell carcinoma arising in Hailey-Disorders of epidermal maturation and keratinization. In: Weedon D. Skin Pathology 2nd ed. Churchill Livingstone; 2002: 298-299.
Weedon D. Disorders of epidermal maturation and keratinization. In: Weedon’s, Skin Pathology. David Weedon (Ed) 2nd ed. Edinburgh, London, New York, Oxford, Philadelphia, St. Louis, Sidney, Toronto: Churchill Livingstone; 2002: 298-299
Burge SM. Hailey–Hailey disease: The clinical features, response to treatmentand prognosis. Br J Dermatol. 1992;126:275-82.
Ikeda S, Suga Y, Ogawa H. Successful management of Hailey–Hailey disease with potent topical steroid ointment. J Dermatol Sci. 1993;5:205–11.
Galimberti RL, Kowalczuk AM, Bianchi O, Bonino MV, Garcia Garcia A. Chronic benign familial pemphigus. Int J Dermatol. 1988;27:495–500.
Marsch W, Stüttgen G. Generalized Hailey–Hailey disease. Br J Dermatol. 1978;99:553–60.
Defresne C, Adam C, De Marneffe K. Pemphigus chronique benin familial de Hailey–Hailey. Dermatologica. 1982;165:624–6.
Mayuzumi N, Ikeda S, Kawada H, Ogawa H. Effects of ultraviolet B irradiation, proinflammatory cytokines and raised extracellular calcium concentration on the expression of ATP2A2 and ATP2C1. Br J Dermatol. 2005;152:697–701.
Mayuzumi N, Ikeda S, Kawada H, Ogawa H. Effects of drugs and anticytokine antibodies on expression of ATP2A2 and ATP2C1 in cultured normal human keratinocytes. Br J Dermatol. 2005;152:920–4.
Leyden J, Marples R. Superinfection induced by antibiotics in familial benign chronic pemphigus. Acta Derm Venereol (Stockh). 1973;53:61–4.
Kellermayer R, Szigeti R, Keeling KM, Bedekovics T, Bedwell DM. Aminoglycosides as potential pharmacogenetic agents in the treatment of Hailey–Hailey disease. J Invest Dermatol. 2006;126:229–31.
Jitsukawa K, Ring J, Weyer U, Kimmig W, Radloff H. Topical cyclosporine in chronic benign familial pemphigus (Hailey–Hailey disease). J Am Acad Dermatol. 1992;27:625–6.
Cecchi R, Bartoli L, Brunetti L. Pemfi go familiare benigno (malattia di Hailey–Hailey) trattato con ciclosporina A orale. G Ital Dermatol Venereol. 1993;128:615–7.
Berth Jones J, Smith SG, GrahamBrown RAC. Benign familial chronic pemphigus(Hailey–Hailey disease) responds to cyclosporin. Clin Expt Dermatol. 1995;20:70–2.
Umar SA, Bhattacharjee P, Brodell RT. Treatment of Hailey–Hailey disease with tacrolimus ointment and clobetasol propionate foam. J Drugs Dermatol. 2004;3:200–3.
Rocha Paris F, Fidalgo A, Baptista J, Caldas LL, Ferreira A. Topical tacrolimus in Hailey–Hailey disease. Int J Tissue React. 2005;27:151–4.
Bianchi L, Chimenti MS, Giunta A. Treatment of Hailey–Hailey disease with topical calcitriol. J Am Acad Dermatol. 2004;51:475–6.
Rajpara SM, King CM. Hailey–Hailey disease responsive to topical calcitriol. BrJ Dermatol. 2005;152:816–7.
Hunt MJ, Salisbury EL, Painter DM, Lee S. Vesiculobullous Hailey–Hailey disease:successful treatment with oral retinoids. Australas J Dermatol. 1996;37:196–8.
Mashiko M, Akiyama M, Tsuji-Abe Y, Shimizu H. Bacterial infection-induced generalized Hailey–Hailey disease successfully treated by etretinate. Clin Exp Dermatol. 2006;31:57–9.
Berger EM, Galadari HI, Gottlieb AB. Successful treatment of Hailey–Haileydisease with acitretin. J Drugs Dermatol. 2007;6:734–6.
Norman R, Greenberg RG, Jackson JM. Case reports of etanercept in infl amatory dermatoses. J Am Acad Dermatol. 2006;4:139–42.
Lapiere JC, Hirsh A, Gordon KB, Cook B, Montalvo A. Botulinum toxin type A for the treatment of axillary Hailey–Hailey disease. Dermatol Surg. 2000;26:371–4.
Konrad H, Karamfi lov T, Wollina U. Intracutaneous botulinum toxin A versusablative therapy of Hailey–Hailey disease—a case report. J Cosmet Laser Ther. 2001;3:181–4.
Kang NG, Yoon TJ, Kim TH. Botulinum toxin type A as an effective adjuvanttherapy for Hailey–Hailey disease. Dermatol Surg. 2002;28:543.